SCHEMBL6207003

SCHEMBL6207003

CCOC(=O)CCCCCCCCCCC(C(=O)OCC)c1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
CYP4F2 P78329 2/20 0.43
CYP4A11 Q02928 2/20 0.43
ALDH1A1 P00352 5/20 0.42
ALOX15 P16050 3/20 0.41
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 1/20 0.40
NAMPT P43490 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.38
USP2 O75604 1/20 0.38
ABL1 P00519 1/20 0.38
HTT P42858 1/20 0.38
RIN1 Q13671 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920116 0.87 MEN1 (0.47) KMT2AMEN1TDP1TSHRPOLB
SCHEMBL6204523 0.83 MEN1 (0.49) KMT2AMEN1ALDH1A1CYP3A4TDP1
SCHEMBL21879787 0.81 LMNA (0.54) ALDH1A1LMNA
SCHEMBL10266928 0.81 ALDH1A1 (0.44) KMT2AMEN1CYP4F2CYP4A11ALDH1A1
SCHEMBL13980904 0.80 MEN1 (0.47) KMT2AMEN1ALDH1A1TDP1POLB
SCHEMBL21879735 0.79 LMNA (0.55) ALDH1A1LMNA
SCHEMBL11386674 0.77 CYP3A4 (0.47) CYP4F2CYP4A11ALDH1A1CYP3A4NAMPT
SCHEMBL5699336 0.77 ESR1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10CYP1A2
SCHEMBL2384369 0.77 ESR1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10CYP1A2
SCHEMBL5699327 0.77 ESR1 (0.44) ALDH1A1CYP3A4TSHRHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1564200-A1 Ketone compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2005-08-17 EP disclosed